Recently added to the BioPortfolio report storeEvolocumab Acute Coronary Syndrome Forecast and Market Analysis to 2023 is a new report fromGlobalData published on 20140730.This 90page reportis available in PDFfrom $3495.Evolocumab Acute Coronary Syndrome ...
↧